Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals.

Iria Rodríguez-OsorioAlvaro MenaHéctor MeijideLuis Enrique MoranoManuel DelgadoPurificación CidLuis MargusinoJosé Domingo PedreiraÁngeles Castro

Published in: PloS one (2019)

The incidence of liver-related events and liver-related mortality was low in older people treated with DAAs and was similar to that in younger patients. The extra mortality in people aged ≥65 years treated with DAAs seems to be secondary to non-liver-related causes. These results support the utilization of DAAs in patients aged ≥65 years.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
cardiovascular events
risk factors
peritoneal dialysis
prognostic factors
type diabetes
cardiovascular disease